Economist Mark Zandi of Moody's Analytics says two states—New York and California—could determine whether the United States ...

Uber Technologies (NYSE: UBER) has outperformed the market over the past 5 years by 6.75% on an annualized basis producing an average annual return of 21.96%. Currently, Uber Technologies has a market ...

Buying $100 In IRM: If an investor had bought $100 of IRM stock 5 years ago, it would be worth $388.20 today based on a price of $102.95 for IRM at the time of writing.

CommScope Holding Co has a lower P/E than the aggregate P/E of 315.21 of the Communications Equipment industry. Ideally, one might believe that the stock might perform worse than its peers, but it's ...

Analysts have provided BRC with 3 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $3.0, suggesting a potential 138.1% upside.

Analysts are estimating that Medifast will report an earnings per share (EPS) of $-0.22. Medifast bulls will hope to hear the company announce they've not only beaten that estimate, but also to ...

Buying $1000 In MA: If an investor had bought $1000 of MA stock 15 years ago, it would be worth $21,537.71 today based on a price of $551.25 for MA at the time of writing.

Analysts anticipate Syndax Pharmaceuticals to report an earnings per share (EPS) of $-0.72. Investors in Syndax Pharmaceuticals are eagerly awaiting the company's announcement, hoping for news of ...

Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.05. The announcement from Myriad Genetics is eagerly anticipated, with investors seeking news of surpassing ...

Oklo shares are trading lower Friday afternoon, continuing a volatile week driven by conflicting catalysts for the nuclear startup.

Debt Management: Castle Biosciences's debt-to-equity ratio is below the industry average. With a ratio of 0.08, the company relies less on debt financing, maintaining a healthier balance between debt ...

V2X (NYSE: VVX) is preparing to release its quarterly earnings on Monday, 2025-11-03. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect V2X to ...